Atorvastatin Versus Revascularization Treatment (AVERT): Fact or fancy?

Balkrishna M. Singh, Sanjeev Puri, Jorge Saucedo, J.David Talley

Open source

DOI
10.1067/mhj.2000.106912
Published
2000-07
Container
American Heart Journal
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1067/mhj.2000.106912,
  title = {Atorvastatin Versus Revascularization Treatment (AVERT): Fact or fancy?},
  author = {Balkrishna M. Singh and Sanjeev Puri and Jorge Saucedo and J.David Talley},
  year = {2000},
  journal = {American Heart Journal},
  doi = {10.1067/mhj.2000.106912},
  url = {https://doi.org/10.1067/mhj.2000.106912}
}

RIS

TY  - JOUR
TI  - Atorvastatin Versus Revascularization Treatment (AVERT): Fact or fancy?
AU  - Balkrishna M. Singh
AU  - Sanjeev Puri
AU  - Jorge Saucedo
AU  - J.David Talley
PY  - 2000
JO  - American Heart Journal
DO  - 10.1067/mhj.2000.106912
UR  - https://doi.org/10.1067/mhj.2000.106912
ER  - 

APA

Singh, B. M., Puri, S., Saucedo, J., & Talley, J. (2000). Atorvastatin Versus Revascularization Treatment (AVERT): Fact or fancy?. American Heart Journal. https://doi.org/10.1067/mhj.2000.106912

Source records